Registered aesthetic nurse Jessica W. answers four of the questions she hears most often about Lenisna and Juvelook, two Korean PDLLA-based collagen biostimulators that are often compared but are designed for different treatment goals.

Q1. Lenisna and Juvelook both contain PDLLA and hyaluronic acid. What is the actual difference between them?

They are from the same treatment family, but I use them quite differently. Both combine poly-D,L-lactic acid, or PDLLA, with non-cross-linked hyaluronic acid. The hyaluronic acid gives some initial hydration and support, while the PDLLA gradually stimulates collagen production over time.1,2

The main difference is the amount and particle size of the PDLLA. Juvelook contains a lower concentration with smaller particles, while Lenisna, also referred to as Juvelook Volume in some studies and markets, contains a higher concentration of PDLLA with larger particles.3,4

In practice, Juvelook is more focused on skin quality. I tend to consider it when I’m treating fine lines, pores, uneven texture, acne scarring or delicate areas such as the under-eye. Lenisna gives me more structural support, so it is better suited to areas where there is greater volume loss, laxity or a need for stronger collagen stimulation.

Q2. How do I know which one would suit my skin better?

I usually decide based on the concern and the depth of treatment needed. If the main issue is fine lines, visible pores, crepey skin or uneven texture, Juvelook may be the more appropriate choice. Clinical studies have reported improvements in skin quality, texture and the under-eye area following Juvelook treatment.3,5

Lenisna comes into the conversation when I want more support from the treatment. Because it contains a higher concentration of PDLLA, I may use it for deeper areas of volume loss, reduced firmness or age-related changes where skin quality alone is not the main concern.4

Neither is automatically better. The choice depends on what I am trying to improve, how thick the skin is, where I am treating and how much structural support the area needs.

Q3. How quickly do the results develop, and how many sessions are usually needed?

These treatments are different from traditional fillers because the result develops gradually. You may notice some initial improvement from the hyaluronic acid and the fluid used during treatment, but the longer-term change comes from collagen stimulation over the following weeks and months.1,2

With Juvelook, I usually recommend a course of treatment. Published studies have commonly used around three sessions spaced approximately one month apart, with skin-quality improvements developing progressively.3,5

Lenisna is more individual. The number of sessions depends on the area, the degree of volume loss and the amount of support required. In both cases, I prefer to build the result gradually so the face continues to look natural rather than suddenly different.

Q4. Are there areas where you would definitely choose one over the other?

Yes, particularly around delicate areas such as the under-eye. Juvelook’s smaller particles and lower PDLLA concentration make it more suitable for superficial treatment and thinner skin when the patient is appropriately selected. Recent clinical research has specifically investigated Juvelook for lower-eyelid and tear-trough rejuvenation.3,6

Lenisna is generally better suited to deeper areas where I want more structural support and collagen stimulation. I would be much more cautious using a higher-concentration PDLLA product superficially, because technique and injection depth are very important with collagen biostimulators. Nodules and other complications can occur if the product is placed incorrectly.7

That is why I always assess the skin, anatomy, previous treatments and degree of volume loss first. The product should follow the patient’s needs, not the other way around.